rimarily minor mucocutaneous bleeding events and minor bleeding at the sites of cardiac catheterization (see PRECAUTIONS, Bleeding Precautions).
Overdosage of AGGRASTAT should be treated by assessment of the condition and cessation or adjustment of the drug infusion as appropriate.
AGGRASTAT can be removed by hemodialysis.
----------------------------------------------------------
CONTRAINDICATIONS
AGGRASTAT is contraindicated in patients with:
known hypersensitivity to any component of the product
active internal bleeding or a history of bleeding diathesis within the previous 30 days
a history of intracranial hemorrhage, intracranial neoplasm, arteriovenous malformation, or aneurysm
a history of thrombocytopenia following prior exposure to AGGRASTAThistory of stroke within 30 days or any history of hemorrhagic stroke
major surgical procedure or severe physical trauma within the previous month
history, symptoms, or findings suggestive of aortic dissection
severe hypertension (systolic blood pressure >180 mmHg and/or diastolic blood pressure >110 mmHg)
concomitant use of another parenteral GP IIb/IIIa inhibitor
acute pericarditis
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=FE0CED75-CCBF-4D2E-BD0D-B57E60AB913F |
